These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17350258)

  • 21. Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibition.
    Warder SE; Tucker LA; McLoughlin SM; Strelitzer TJ; Meuth JL; Zhang Q; Sheppard GS; Richardson PL; Lesniewski R; Davidsen SK; Bell RL; Rogers JC; Wang J
    J Proteome Res; 2008 Nov; 7(11):4807-20. PubMed ID: 18828628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolites of PPI-2458, a selective, irreversible inhibitor of methionine aminopeptidase-2: structure determination and in vivo activity.
    Arico-Muendel CC; Belanger B; Benjamin D; Blanchette HS; Caiazzo TM; Centrella PA; DeLorey J; Doyle EG; Gradhand U; Griffin ST; Hill S; Labenski MT; Morgan BA; O'Donovan G; Prasad K; Skinner S; Taghizadeh N; Thompson CD; Wakefield J; Westlin W; White KF
    Drug Metab Dispos; 2013 Apr; 41(4):814-26. PubMed ID: 23355637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of human methionine aminopeptidase-2 complexed with fumagillin.
    Liu S; Widom J; Kemp CW; Crews CM; Clardy J
    Science; 1998 Nov; 282(5392):1324-7. PubMed ID: 9812898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression.
    Hu X; Addlagatta A; Lu J; Matthews BW; Liu JO
    Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18148-53. PubMed ID: 17114291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates.
    Heinrich T; Buchstaller HP; Cezanne B; Rohdich F; Bomke J; Friese-Hamim M; Krier M; Knöchel T; Musil D; Leuthner B; Zenke F
    Bioorg Med Chem Lett; 2017 Feb; 27(3):551-556. PubMed ID: 27998678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human methionine aminopeptidase type 2 in complex with L- and D-methionine.
    Nonato MC; Widom J; Clardy J
    Bioorg Med Chem Lett; 2006 May; 16(10):2580-3. PubMed ID: 16540317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity.
    Morgen M; Jöst C; Malz M; Janowski R; Niessing D; Klein CD; Gunkel N; Miller AK
    ACS Chem Biol; 2016 Apr; 11(4):1001-11. PubMed ID: 26686773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of novel anthranilic acids as antibacterial agents. Extensive evaluation of alternative amide bioisosteres connecting the A- and the B-rings.
    Thorarensen A; Wakefield BD; Romero DL; Marotti KR; Sweeney MT; Zurenko GE; Rohrer DC; Han F; Bryant GL
    Bioorg Med Chem Lett; 2007 May; 17(10):2823-7. PubMed ID: 17368020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of alpha-hydroxy-beta-amino acid inhibitors to methionine aminopeptidase. The performance of two types of scoring functions.
    Jørgensen AT; Sørensen MD; Björkling F; Liljefors T
    J Comput Aided Mol Des; 2003; 17(5-6):383-97. PubMed ID: 14635729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and anti-inflammatory evaluation of N-sulfonyl anthranilic acids via Ir(III)-catalyzed C-H amidation of benzoic acids.
    Han SH; Suh HS; Jo H; Oh Y; Mishra NK; Han S; Kim HS; Jung YH; Lee BM; Kim IS
    Bioorg Med Chem Lett; 2017 May; 27(10):2129-2134. PubMed ID: 28389150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metal mediated inhibition of methionine aminopeptidase by quinolinyl sulfonamides.
    Huang M; Xie SX; Ma ZQ; Hanzlik RP; Ye QZ
    Biochem Biophys Res Commun; 2006 Jan; 339(2):506-13. PubMed ID: 16300729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metal ions as cofactors for the binding of inhibitors to methionine aminopeptidase: a critical view of the relevance of in vitro metalloenzyme assays.
    Schiffmann R; Heine A; Klebe G; Klein CD
    Angew Chem Int Ed Engl; 2005 Jun; 44(23):3620-3. PubMed ID: 15880695
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors.
    Oza VB; Petrassi HM; Purkey HE; Kelly JW
    Bioorg Med Chem Lett; 1999 Jan; 9(1):1-6. PubMed ID: 9990446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 1.
    Cheruvallath Z; Tang M; McBride C; Komandla M; Miura J; Ton-Nu T; Erikson P; Feng J; Farrell P; Lawson JD; Vanderpool D; Wu Y; Dougan DR; Plonowski A; Holub C; Larson C
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2774-2778. PubMed ID: 27155900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
    Zhou G; Tsai CW; Liu JO
    J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model.
    Chun E; Han CK; Yoon JH; Sim TB; Kim YK; Lee KY
    Int J Cancer; 2005 Mar; 114(1):124-30. PubMed ID: 15523682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cis-fumagillin, a new methionine aminopeptidase (type 2) inhibitor produced by Penicillium sp. F2757.
    Kwon JY; Jeong HW; Kim HK; Kang KH; Chang YH; Bae KS; Choi JD; Lee UC; Son KH; Kwon BM
    J Antibiot (Tokyo); 2000 Aug; 53(8):799-806. PubMed ID: 11079802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfoximine directed intermolecular o-C-H amidation of arenes with sulfonyl azides.
    Yadav MR; Rit RK; Sahoo AK
    Org Lett; 2013 Apr; 15(7):1638-41. PubMed ID: 23477353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides.
    Kim S; LaMontagne K; Sabio M; Sharma S; Versace RW; Yusuff N; Phillips PE
    Cancer Res; 2004 May; 64(9):2984-7. PubMed ID: 15126329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthranilic acid based CCK1 receptor antagonists: blocking the receptor with the same 'words' of the endogenous ligand.
    Lassiani L; Pavan MV; Berti F; Kokotos G; Markidis T; Mennuni L; Makovec F; Varnavas A
    Bioorg Med Chem; 2009 Mar; 17(6):2336-50. PubMed ID: 19261479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.